IRIS UniCatt

Nero, Camilla
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.279
AS - Asia 2.177
EU - Europa 1.580
SA - Sud America 457
AF - Africa 53
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 6.555
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.179
SG - Singapore 986
IT - Italia 446
CN - Cina 424
BR - Brasile 360
DE - Germania 242
SE - Svezia 240
VN - Vietnam 225
FR - Francia 136
HK - Hong Kong 116
IN - India 114
GB - Regno Unito 103
IE - Irlanda 85
FI - Finlandia 79
ID - Indonesia 64
JP - Giappone 61
UA - Ucraina 60
NL - Olanda 45
CA - Canada 41
RU - Federazione Russa 38
BD - Bangladesh 34
AR - Argentina 31
MX - Messico 31
KR - Corea 29
AT - Austria 21
IQ - Iraq 19
PL - Polonia 19
BE - Belgio 16
EC - Ecuador 16
TR - Turchia 15
ES - Italia 14
PH - Filippine 14
ZA - Sudafrica 14
IR - Iran 11
MA - Marocco 11
CO - Colombia 10
PK - Pakistan 10
CL - Cile 9
VE - Venezuela 9
SA - Arabia Saudita 8
PE - Perù 7
PY - Paraguay 7
UZ - Uzbekistan 7
CI - Costa d'Avorio 6
CZ - Repubblica Ceca 6
IL - Israele 6
JO - Giordania 6
HN - Honduras 5
KG - Kirghizistan 5
JM - Giamaica 4
KE - Kenya 4
KZ - Kazakistan 4
LT - Lituania 4
MY - Malesia 4
NG - Nigeria 4
RO - Romania 4
TT - Trinidad e Tobago 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
DO - Repubblica Dominicana 3
EG - Egitto 3
HU - Ungheria 3
LB - Libano 3
NI - Nicaragua 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
TN - Tunisia 3
UY - Uruguay 3
AL - Albania 2
AO - Angola 2
AW - Aruba 2
BO - Bolivia 2
CH - Svizzera 2
DZ - Algeria 2
GF - Guiana Francese 2
HR - Croazia 2
MD - Moldavia 2
MN - Mongolia 2
PR - Porto Rico 2
SI - Slovenia 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CR - Costa Rica 1
DM - Dominica 1
GE - Georgia 1
GI - Gibilterra 1
GT - Guatemala 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LY - Libia 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 6.550
Salva come PNG Salva come JPEG
Città #
Singapore 568
Ashburn 282
Chandler 272
San Jose 264
Rome 168
Hong Kong 107
Beijing 90
New York 84
Dublin 80
Ho Chi Minh City 71
Hefei 68
Los Angeles 65
Hanoi 63
The Dalles 60
Hyderabad 57
Tokyo 56
Ann Arbor 54
Milan 54
Jakarta 53
Lauterbourg 52
Frankfurt am Main 42
Columbus 41
Munich 41
Helsinki 40
San Mateo 40
Dallas 35
São Paulo 34
Council Bluffs 32
Boston 30
Wilmington 30
St Louis 28
Jacksonville 27
Nanjing 23
Orem 23
Seoul 23
Moscow 22
Princeton 20
Cattolica 19
Kent 19
Marseille 18
Dearborn 17
Santa Clara 17
Nuremberg 16
Rio de Janeiro 16
Vienna 16
Buffalo 15
London 15
Atlanta 14
Bari 14
Brooklyn 14
Brussels 14
Houston 14
Turku 14
Boardman 13
Lappeenranta 13
Montreal 12
Paris 12
Phoenix 12
Stockholm 12
Warsaw 12
Amsterdam 11
Bexley 11
Fairfield 11
Lawrence 11
Nürnberg 11
Chicago 10
Johannesburg 10
Mexico City 10
Seattle 10
Toronto 10
Denver 9
Leawood 9
Washington 9
Woodbridge 9
Baghdad 8
Brasília 8
Düsseldorf 8
North Bergen 8
Poplar 8
Redwood City 8
Shanghai 8
Bremen 7
Chennai 7
Da Nang 7
San Francisco 7
Vancouver 7
Abidjan 6
Amman 6
Campinas 6
Fortaleza 6
Guangzhou 6
Newark 6
Querétaro 6
Quito 6
Roubaix 6
Tashkent 6
Turin 6
Andover 5
Augusta 5
Dhaka 5
Totale 3.750
Salva come PNG Salva come JPEG
Nome #
Patient-derived organoids and high grade serous ovarian cancer: from disease modeling to personalized medicine 202
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience. 181
Privacy in Italian Clinical Reports: A NLP-Based Anonymization Approach 173
A laparoscopic risk-adjusted model to predict major complications after primary debulking surgery in ovarian cancer: A single-institution assessment 171
Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 168
Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids 154
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience 151
Building a personalized medicine infrastructure for gynecological oncology patients in a high-volume hospital 145
Back to the future: The impact of oestrogen receptor profile in the era of molecular endometrial cancer classification 139
Deep-Learning to Predict BRCA Mutation and Survival from Digital H&E Slides of Epithelial Ovarian Cancer 138
Epithelial ovarian cancer and brain metastases: might the BRCA status, PARP inhibitor administration, and surgical treatment impact the survival? 137
Infiltrating T lymphocytes and programmed cell death protein-1/programmed death-ligand 1 expression in endometriosis-associated ovarian cancer 137
Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study 132
Targeting the hallmarks of ovarian cancer: The big picture 131
Pathologic response to neoadjuvant chemotherapy in advanced ovarian cancer: utility of a scoring system to predict outcomes 129
Impact of Comprehensive Genome Profiling on the Management of Advanced Non–Small Cell Lung Cancer: Preliminary Results From the Lung Cancer Cohort of the FPG500 Program 128
Pd-l1 expression on circulating tumour-derived microvesicles as a complementary tool for stratification of high-grade serous ovarian cancer patients 125
One-Step Nucleic Acid Amplification (OSNA): A fast molecular test based on CK19 mRNA concentration for assessment of lymph-nodes metastases in early stage endometrial cancer 124
A cost-effectiveness analysis of an integrated clinical-radiogenomic screening program for the identification of BRCA 1/2 carriers (e-PROBE study 123
Robotic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective Phase II Study 123
Characterization of shared neoantigens landscape in Mismatch Repair Deficient Endometrial Cancer 122
Integrating a Comprehensive Cancer Genome Profiling into Clinical Practice: A Blueprint in an Italian Referral Center 121
Sentinel-node biopsy in apparent early stage ovarian cancer: final results of a prospective multicentre study (SELLY) 120
Radiomics analysis of ultrasound images to discriminate between benign and malignant adnexal masses with solid morphology on ultrasound 120
Laparoscopic Management of a Small Bowel Recurrence of Endometrial Cancer 119
Recent progress in the use of pharmacotherapy for endometrial cancer 117
Emerging role of immune checkpoint inhibitors in the treatment of ovarian cancer 115
PARP Inhibitors Resistance: Mechanisms and Perspectives 114
Assessment of preoperative nutritional status using BIA-derived phase angle (PhA) in patients with advanced ovarian cancer: Correlation with the extent of cytoreduction and complications 114
The immunohistochemical molecular risk classification in endometrial cancer: A pragmatic and high-reproducibility method 114
Integrating clinical-molecular data to predict PARP inhibitors efficacy in advanced ovarian cancer patients after interval cytoreductive surgery 112
Advanced and recurrent endometrial cancer: State of the art and future perspectives 110
Secondary Laparoscopic Cytoreduction in Recurrent Ovarian Cancer: A Large, Single-Institution Experience 109
Mesenteric lymph node involvement in advanced ovarian cancer patients undergoing rectosigmoid resection: Prognostic role and clinical considerations 107
Correction: Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study 106
Are all mismatch repair deficient endometrial cancers created equal? A large, retrospective, tertiary center experience 105
Laparoscopic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective Phase II Study 105
Oregovomab: an investigational agent for the treatment of advanced ovarian cancer 100
Germline BRCA 1-2 status prediction through ovarian ultrasound images radiogenomics: a hypothesis generating study (PROBE study) 98
Robotic Splenectomy for Isolated Splenic Recurrence of Endometrial Adenocarcinoma 95
Further refining 2020 ESGO/ESTRO/ESP molecular risk classes in patients with early-stage endometrial cancer: A propensity score–matched analysis 93
Newly diagnosed ovarian cancer: Which first-line treatment? 92
Laparotomy approach to sentinel lymph node detection in ovarian cancer using a near-infrared fluorescent system camera with indocyanine green dye 91
Systematic Review of Cytoreductive Surgery and Bevacizumab-Containing Chemotherapy in Advanced Ovarian Cancer: Focus on Safety 90
Preclinical and Clinical Evidence of Lurbinectedin in Ovarian Cancer: Current Status and Future Perspectives 89
Sentinel-node biopsy in early-stage ovarian cancer: preliminary results of a prospective multicentre study (SELLY) 88
Sentinel-node biopsy in early stage ovarian cancer: a prospective multicentre study (SELLY) 86
Radiomics and Radiogenomics of Ovarian Cancer: Implications for Treatment Monitoring and Clinical Management 84
L1CAM Expression in Microcystic, Elongated, and Fragmented (MELF) Glands Predicts Lymph Node Involvement in Endometrial Carcinoma 83
Verification of the prognostic precision of the new 2023 FIGO staging system in endometrial cancer patients - An international pooled analysis of three ESGO accredited centres 81
Laparoscopic Splenectomy for Secondary Cytoreduction in Ovarian Cancer Patients With Localized Spleen Recurrence: Feasibility and Technique 81
Minilaparoscopic Aortic Lymphadenectomy 71
Ovarian cancer patients with localized relapse: Clinical outcome and prognostic factors 70
Management of stage III and IVa uterine cancer 69
Timing and Pattern of Recurrence in Ovarian Cancer Patients with High Tumor Dissemination Treated with Primary Debulking Surgery Versus Neoadjuvant Chemotherapy 65
Mesenteric Lymph Node Involvement in Advanced Ovarian Cancer Patients Undergoing Rectosigmoid Resection: Prognostic Role and Clinical Considerations 62
Back to the future: The impact of oestrogen receptor profile in the era of molecular endometrial cancer classification 58
Electronic nose-based volatile organic compound profiling in gynecologic oncology: current evidence and diagnostic accuracy 46
A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group 44
Circulating tumor DNA in endometrial cancer: clinical significance and implications 38
Image-guided real-time optical biopsy in oncologic surgery: a systematic review of the role of confocal microscopy in the era of digital surgery 38
Circulating tumor DNA as a biomarker for predicting progression-free survival and overall survival in patients with epithelial ovarian cancer: a systematic review and meta-analysis 28
Totale 6.681
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.269
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.269
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202146 0 0 0 0 0 0 0 0 0 10 29 7
2021/2022312 12 13 4 24 18 5 15 55 15 27 49 75
2022/2023737 93 96 52 115 37 91 34 53 74 16 32 44
2023/2024523 12 116 23 47 26 57 43 33 5 30 65 66
2024/20251.350 39 28 96 60 91 63 63 50 153 168 311 228
2025/20263.242 391 225 224 420 562 197 561 198 261 203 0 0
Totale 6.681